Display options
Cite
Surowiec P, Matejko B, Kopka M, et al. Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment. Endocrine. 2021;doi: 10.1007/s12020-021-02871-2.
Surowiec, P., Matejko, B., Kopka, M., Filemonowicz-Skoczek, A., Klupa, T., Cyganek, K., Romanowska-Dixon, B., & Malecki, M. T. (2021). Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment. Endocrine, . https://doi.org/10.1007/s12020-021-02871-2
Surowiec, Paulina, et al. "Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment." Endocrine vol. (2021). doi: https://doi.org/10.1007/s12020-021-02871-2
Surowiec P, Matejko B, Kopka M, Filemonowicz-Skoczek A, Klupa T, Cyganek K, Romanowska-Dixon B, Malecki MT. Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment. Endocrine. 2021 Sep 20; doi: 10.1007/s12020-021-02871-2. Epub 2021 Sep 20. PMID: 34542802.
Copy Download .nbib Format: NLM
Share it on

Endocrine. 2021 Sep 20; doi: 10.1007/s12020-021-02871-2. Epub 2021 Sep 20.

Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment.

Endocrine

Paulina Surowiec, Bartłomiej Matejko, Marianna Kopka, Agnieszka Filemonowicz-Skoczek, Tomasz Klupa, Katarzyna Cyganek, Bożena Romanowska-Dixon, Maciej T Malecki

Affiliations

  1. Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.
  2. University Hospital, Krakow, Poland.
  3. Department of Ophthalmology, Jagiellonian University Medical College, Kraków, Poland.
  4. Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland. [email protected].
  5. University Hospital, Krakow, Poland. [email protected].

PMID: 34542802 DOI: 10.1007/s12020-021-02871-2

Abstract

PURPOSE: Despite progress in type 1 diabetes (T1DM) therapy, diabetic retinopathy (DR) is still a common complication. We analysed predictors and prevalence of DR in patients with T1DM lasting 10 years or more. All of the patients were considered to be currently in excellent glycemic control and treated using modern therapies.

METHODS: Study included 384 (80.7% women) T1DM patients participating in the Program of Comprehensive Outpatient Specialist Care at the University Hospital in Krakow between the years 2014 and 2020. A retrospective analysis of medical records was conducted.

RESULTS: The patients were on average 34 ± 9.2 years old, had a BMI 25.0 ± 3.9 and a T1DM duration of 20.5 ± 7.9 years. The mean level of HbA1c throughout the follow-up (mean duration 4.9 ± 1.4 years) was 6.9 ± 1%. The group included 238 (62.0%) patients treated with insulin pumps and 99 (25.8%) on multiple daily injections, 47 (12.2%) used both methods; almost all patients were on insulin analogues. DR was confirmed in 150 (39.1%) patients, from which 109 (28.4%) were diagnosed de novo. Severe DR was occurred in just 31 cases (8.1%). In the multivariate logistic regression, independent risk factors for the presence of DR were T1DM duration (OR 1.13; 95% CI, 1.09-1.19), HbA1c level (OR 1.41; 95% CI, 1.08-1.84), LDL level (OR 1.79; 95% CI, 1.16-2.87), and the combined presence of non-DR micro- and macrovascular chronic complications (OR 1.86; 95% CI, 1.16-3.03).

CONCLUSIONS: In this highly-selected group of T1DM patients, mostly female, the prevalence of both DR at any stage and severe DR was lower than earlier reported results from other cohorts. Independent risk factors for the DR cohort did not differ from previously reported studies.

© 2021. The Author(s).

Keywords: Diabetic retinopathy; Risk factors; Type 1 diabetes

References

  1. N. Cheung, P. Mitchell, T.Y. Wong, Diabetic retinopathy. Lancet 376(Jul 9735), 124–136 (2010). https://doi.org/10.1016/S0140-6736(09)62124-3 . Epub 2010 Jun 26. PMID: 20580421 - PubMed
  2. R.R. Bourne, G.A. Stevens, R.A. White, J.L. Smith, S.R. Flaxman, H. Price, J.B. Jonas, J. Keeffe, J. Leasher, K. Naidoo, K. Pesudovs, S. Resnikoff, H.R. Taylor, Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob. Health 1(Dec 6), e339–e349 (2013). https://doi.org/10.1016/S2214-109X(13)70113-X . Vision Loss Expert GroupEpub 2013 Nov 11. PMID: 25104599 - PubMed
  3. J.F. Esteves, M.M. Dal Pizzol, C.A. Sccoco, M.F. Roggia, S.B. Milano, J.A. Guarienti, T.C. Rodrigues, L.H. Canani, Cataract and type 1 diabetes mellitus. Diabetes Res Clin. Pract. 82(Dec 3), 324–328 (2008). https://doi.org/10.1016/j.diabres.2008.08.023 . Epub 2008 Oct 15. PMID: 18926582 - PubMed
  4. D. Zhao, J. Cho, M.H. Kim, D.S. Friedman, Guallar E. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology 122(Jan 1), 72–78 (2015). https://doi.org/10.1016/j.ophtha.2014.07.051 . Epub 2014 Oct 3. PMID: 25283061 - PubMed
  5. R. Simó, C.D.A. Stehouwer, A. Avogaro, Diabetic retinopathy: looking beyond the eyes. Diabetologia 63(Aug 8), 1662–1664 (2020). https://doi.org/10.1007/s00125-020-05195-4 . Epub 2020 Jun 18. PMID: 32556614 - PubMed
  6. R. Simó, J. Bañeras, C. Hernández, J. Rodríguez-Palomares, F. Valente, L. Gutierrez, T. González-Alujas, I. Ferreira, S. Aguadé-Bruix, J. Montaner, D. Seron, J. Genescà, A. Boixadera, J. García-Arumí, A. Planas, O. Simó-Servat, D. García-Dorado, Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study. BMJ Open Diabetes Res. Care. 7(Dec 1), e000845 (2019). https://doi.org/10.1136/bmjdrc-2019-000845 . PMID: 31908800; PMCID: PMC6936469 - PubMed
  7. J. Xie, M.K. Ikram, M.F. Cotch, B. Klein, R. Varma, J.E. Shaw, R. Klein, P. Mitchell, E.L. Lamoureux, T.Y. Wong, Association of diabetic macular edema and proliferative diabetic retinopathy cardiovascular disease: a systematic review and meta-analysis. JAMA Ophthalmol. 135(Jun 6), 586–593 (2017). PMID: 28472362; PMCID: PMC5593137 https://doi.org/10.1001/jamaophthalmol.2017.0988 - PubMed
  8. J.W. Yau, S.L. Rogers, R. Kawasaki, E.L. Lamoureux, J.W. Kowalski, T. Bek, S.J. Chen, J.M. Dekker, A. Fletcher, J. Grauslund, S. Haffner, R.F. Hamman, M.K. Ikram, T. Kayama, B.E. Klein, R. Klein, S. Krishnaiah, K. Mayurasakorn, J.P. O’Hare, T.J. Orchard, M. Porta, M. Rema, M.S. Roy, T. Sharma, J. Shaw, H. Taylor, J.M. Tielsch, R. Varma, J.J. Wang, N. Wang, S. West, L. Xu, M. Yasuda, X. Zhang, P. Mitchell, T.Y. Wong, Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 35(Mar 3), 556–564 (2012). https://doi.org/10.2337/dc11-1909 . Epub 2012 Feb 1. PMID: 22301125; PMCID: PMC3322721 - PubMed
  9. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, D.L. DeMets, The Wisconsin epidemiologic study of diabetic retinopathy. III Prevalence and risk of Diabetic retinopathy when age diagnosis is 30 or more years. Arch. Ophthalmol. 102(Apr 4), 527–532 (1984). PMID: 6367725 https://doi.org/10.1001/archopht.1984.01040030405011 - PubMed
  10. S.Y. Wang, C.A. Andrews, W.H. Herman, T.W. Gardner, J.D. Stein, Incidence and risk factors for developing diabetic retinopathy among youths with Type 1 or Type 2 diabetes throughout the United States. Ophthalmology 124(Apr 4), 424–430 (2017). https://doi.org/10.1016/j.ophtha.2016.10.031 . Epub 2016 Nov 30. PMID: 27914837; PMCID: PMC5728116 - PubMed
  11. R.W. Jansson, K.O. Hufthammer, J. Krohn, Diabetic retinopathy in type 1 diabetes patients in Western Norway. Acta Ophthalmol. 96(Aug 5), 465–474 (2018). https://doi.org/10.1111/aos.13654 . Epub 2018 Jan 25. PMID: 29369506 - PubMed
  12. R.L. Thomas, F.D. Dunstan, S.D. Luzio, S.R. Chowdhury, R.V. North, S.L. Hale, R.L. Gibbins, D.R. Owens, Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br. J. Ophthalmol. 99(Jan 1), 64–68 (2015). https://doi.org/10.1136/bjophthalmol-2013-304017 . Epub 2014 Aug 4. PMID: 25091950 - PubMed
  13. E.J. Mayer-Davis, C. Davis, J. Saadine, R.B. D’Agostino Jr, D. Dabelea, L. Dolan, S. Garg, J.M. Lawrence, C. Pihoker, B.L. Rodriguez, B.E. Klein, R. Klein; SEARCH for Diabetes in Youth Study Group, Diabetic retinopathy in the SEARCH for diabetes in youth cohort: a pilot study. Diabet. Med. 29(Sep 9), 1148–1152 (2012). https://doi.org/10.1111/j.1464-5491.2012.03591.x . PMID: 22269205; PMCID: PMC4495729 - PubMed
  14. C. Madeira, M. Lopes, R. Laiginhas, J. Neves, V. Rosas, M. Barbosa, D. Carvalho, F. Falcão-Reis, M. Falcão, Changing trends in the prevalence of diabetic retinopathy in type 1 diabetes mellitus from 1990 to 2018: a retrospective study in a Portuguese population. Diabetes Res Clin Pract 158(Dec), 107891 (2019). https://doi.org/10.1016/j.diabres.2019.107891 . Epub 2019 Oct 24. PMID: 31669626 - PubMed
  15. J.P. Kytö, V. Harjutsalo, C. Forsblom, K. Hietala, P.A. Summanen, P.H. Groop; FinnDiane Study Group, Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care. 34(Sep 9), 2005–2007 (2011). https://doi.org/10.2337/dc10-2391 . PMID: 21868777; PMCID: PMC3161282 - PubMed
  16. UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317(Sep 7160), 703–713 (1998). Erratum in: BMJ 1999 Jan 2;318(7175):29. PMID: 9732337; PMCID: PMC28659 - PubMed
  17. P.H. Gallego, M.E. Craig, S. Hing, K.C. Donaghue, Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. BMJ 337(Aug), a918 (2008). https://doi.org/10.1136/bmj.a918 . PMID: 18728082; PMCID: PMC2526183 - PubMed
  18. D.P. Hainsworth, I. Bebu, L.P. Aiello, W. Sivitz, R. Gubitosi-Klug, J. Malone, N.H. White, R. Danis, A. Wallia, X. Gao, A.J. Barkmeier, A. Das, S. Patel, T.W. Gardner, J.M. Lachin, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Risk factors for retinopathy in type 1 diabetes: The DCCT/EDIC Study. Diabetes Care. 42(May 5), 875–882 (2019). https://doi.org/10.2337/dc18-2308 . Epub 2019 Mar 4. PMID: 30833368; PMCID: PMC6489114 - PubMed
  19. T. Bulum, M. Tomić, L. Duvnjak, Total serum cholesterol increases risk for development and progression of nonproliferative retinopathy in patients with type 1 diabetes without therapeutic intervention: prospective, observational study. Arch. Med Res. 48(Jul 5), 467–471 (2017). https://doi.org/10.1016/j.arcmed.2017.10.003 . Epub 2017 Oct 28. PMID: 29089151 - PubMed
  20. ACCORD Study Group; ACCORD Eye Study Group, E.Y. Chew, W.T. Ambrosius, M.D. Davis, R.P. Danis, S. Gangaputra, C.M. Greven, L. Hubbard, B.A. Esser, J.F. Lovato, L.H. Perdue, D.C. Goff Jr, W.C. Cushman, H.N. Ginsberg, M.B. Elam, S. Genuth, H.C. Gerstein, U. Schubart, L.J. Fine, Effects of medical therapies on retinopathy progression in type 2 diabetes. N. Engl. J. Med. 363(Jul 3), 233–244 (2010). https://doi.org/10.1056/NEJMoa1001288 . Epub 2010 Jun 29. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. Erratum in: N Engl J Med. 2012 Dec 20;367(25):2458. PMID: 20587587; PMCID - PubMed
  21. J.N. Harvey, The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy. Diabetologia 54(Aug 8), 1943–1945 (2011). https://doi.org/10.1007/s00125-011-2185-6 . Epub 2011 May 21. PMID - PubMed
  22. Diabetes Control and Complications Trial Research Grou, Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care. 23(Aug 8), 1084–1091 (2000). https://doi.org/10.2337/diacare.23.8.1084 . PMID: 10937502; PMCID: PMC2631985 - PubMed
  23. R.O. Estacio, E. McFarling, S. Biggerstaff, B.W. Jeffers, D. Johnson, R.W. Schrier, Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am. J. Kidney Dis. 31(Jun 6), 947–953 (1998). https://doi.org/10.1053/ajkd.1998.v31.pm9631838 . PMID: 9631838 - PubMed
  24. Diabetes Control and Complications Trial Research Group, D.M. Nathan, S. Genuth, J. Lachin, P. Cleary, O. Crofford, M. Davis, L. Rand, C. Siebert, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med 329(Sep 14), 977–986 (1993). https://doi.org/10.1056/NEJM199309303291401 . PMID: 8366922 - PubMed
  25. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 352(Sep 9131), 837–853 (1998). Erratum in: Lancet 1999 Aug 14;354(9178):602. PMID: 9742976 - PubMed
  26. J.M. Lachin, N.H. White, D.P. Hainsworth, W. Sun, P.A. Cleary, D.M. Nathan, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes 64(Feb 2), 631–642 (2015). Epub 2014 Sep 9. PMID: 25204977; PMCID: PMC4303965 https://doi.org/10.2337/db14-0930 - PubMed
  27. J. Šoupal, L. Petruželková, G. Grunberger, A. Hásková, M. Flekač, M. Matoulek, O. Mikeš, T. Pelcl, J. Škrha Jr, E. Horová, J. Škrha, C.G. Parkin, Š. Svačina, M. Prázný, Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study. Diabetes Care. 43(Jan 1), 37–43 (2020). https://doi.org/10.2337/dc19-0888 . Epub 2019 Sep 17. PMID: 31530663 - PubMed
  28. B. Zabeen, M.E. Craig, S.A. Virk, A. Pryke, A.K. Chan, Y.H. Cho, P.Z. Benitez-Aguirre, S. Hing, K.C. Donaghue, Insulin pump therapy is associated with lower rates of retinopathy and peripheral nerve abnormality. PLoS ONE 11(Apr 4), e0153033 (2016). https://doi.org/10.1371/journal.pone.0153033 . PMID: 27050468; PMCID: PMC4822832 - PubMed
  29. E. Downie, M.E. Craig, S. Hing, J. Cusumano, A.K. Chan, K.C. Donaghue, Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care. 34(Nov 11), 2368–2373 (2011). https://doi.org/10.2337/dc11-0102 . PMID: 22025782; PMCID: PMC3198305 - PubMed
  30. American Academy of Ophthalmology. Diabetic retinopathy preferred practise pattern 2019, P66-P147. https://doi.org/10.1016/j.ophtha.2019.09.025 , entrance date: 5.02.2020 - PubMed
  31. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 98(Oct 4S), S1–S115 (2020). https://doi.org/10.1016/j.kint.2020.06.019 . PMID: 32998798 - PubMed
  32. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M.J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P.P. Filardi, G. Riccardi, R.F. Storey, D. Wood, European Association for Cardiovascular Prevention & Rehabilitation, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees, ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 32(Jul 14), 1769–1818 (2011). Epub 2011 Jun 28. PMID: 21712404 https://doi.org/10.1093/eurheartj/ehr158 - PubMed
  33. AlbericoL. Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M.John Chapman, Heinz Drexel, ArnoW. Hoes, CatrionaS. Jennings, Ulf Landmesser, TerjeR. Pedersen, Željko Reiner, Gabriele Riccardi, Marja-Riita Taskinen, Lale Tokgozoglu, W.M.Monique Verschuren, Charalambos Vlachopoulos, DavidA. Wood, JoseLuis Zamorano, Marie-Therese Cooney; ESC Scientific Document Group, 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 37(Issue 39 October), 2999–3058 (2016). https://doi.org/10.1093/eurheartj/ehw272 . entrance date 5.02.2020 - PubMed
  34. F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.R. Taskinen, L. Tokgozoglu, O. Wiklund; ESC Scientific Document Group, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 41(Jan 1), 111–188 (2020). https://doi.org/10.1093/eurheartj/ehz455 . PMID: 31504418 - PubMed
  35. P.W. Witek, P. Wolkow, J. Stancel-Mozwiłło, K. Wojtyczek, J. Sieradzki, M. Malecki, The Polish diabetes registry for adults - A pilot study. Diabetologia Kliniczna 1(January), 3–11 (2012) - PubMed
  36. M. Kozioł, M.S. Nowak, M. Udziela, P. Piątkiewicz, I. Grabska-Liberek, J.P. Szaflik, First nation-wide study of diabetic retinopathy in Poland in the years 2013–2017. Acta Diabetol. 57(Oct 10), 1255–1264 (2020). https://doi.org/10.1007/s00592-020-01540-6 . Epub 2020 Jun 4. PMID: 32500357; PMCID: PMC7495995 - PubMed
  37. E. Heintz, A.B. Wiréhn, B.B. Peebo, U. Rosenqvist, L.A. Levin, Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 53(Oct 10), 2147–2154 (2010). https://doi.org/10.1007/s00125-010-1836-3 . Epub 2010 Jul 2. PMID: 20596693 - PubMed
  38. M.B. Larsen, J.E. Henriksen, J. Grauslund, T. Peto, Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark. Acta Ophthalmol. 95(Dec 8), 778–786 (2017). https://doi.org/10.1111/aos.13449 . Epub 2017 Apr 26. PMID: 28444837 - PubMed
  39. American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care. 44 (Jan Suppl 1), S151–S167 (2021). https://doi.org/10.2337/dc21-S011 . PMID: 33298422 - PubMed
  40. 2020 Guidelines on the management of diabetic patients, A position of Diabetes Poland. Clin. Diabetol. 9(1), 1–101 (2020). - PubMed
  41. DCCT/EDIC Research Group, D.M. Nathan, I. Bebu, D. Hainsworth, R. Klein, W. Tamborlane, G. Lorenzi, R. Gubitosi-Klug, J.M. Lachin, Frequency of evidence-based screening for retinopathy in type 1 diabetes. N. Engl. J. Med. 376(Apr 16), 1507–1516 (2017). https://doi.org/10.1056/NEJMoa1612836 . PMID: 28423305; PMCID: PMC5557280 - PubMed
  42. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, D.L. DeMets, Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260(Nov 19), 2864–2871 (1988). PMID: 3184351 - PubMed
  43. L.P. Aiello,DCCT/EDIC Research Group, Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 37(1), 17–23 (2014). PMID: 24356593; PMCID: PMC3867989 https://doi.org/10.2337/dc13-2251 - PubMed
  44. E.Y. Chew, M.L. Klein, F.L. Ferris 3rd, N.A. Remaley, R.P. Murphy, K. Chantry, B.J. Hoogwerf, D. Miller, Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch. Ophthalmol. 114(Sep 9), 1079–1084 (1996). https://doi.org/10.1001/archopht.1996.01100140281004 . PMID: 8790092 - PubMed
  45. M.F. Lopes-Virella, N.L. Baker, K.J. Hunt, T.J. Lyons, A.J. Jenkins, G. Virella,DCCT/EDIC Study Group, High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care. 35(Jun 6), 1333–1340 (2012). Epub 2012 Apr 17. PMID: 22511260; PMCID: PMC3357232 https://doi.org/10.2337/dc11-2040 - PubMed
  46. Y. Zhou, C. Wang, K. Shi, X. Yin, Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Med. (Baltim.). 97(Sep 36), e12283 (2018). https://doi.org/10.1097/MD.0000000000012283 . PMID: 30200172; PMCID: PMC6133445 - PubMed
  47. A.C. Keech, P. Mitchell, P.A. Summanen, J. O’Day, T.M. Davis, M.S. Moffitt, M.R. Taskinen, R.J. Simes, D. Tse, E. Williamson, A. Merrifield, L.T. Laatikainen, M.C. d’Emden, D.C. Crimet, R.L. O’Connell, P.G. Colman, FIELD study investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 370(Nov 9600), 1687–e12297 (2007). https://doi.org/10.1016/S0140-6736(07)61607-9 . Epub 2007 Nov 7. PMID: 17988728 - PubMed
  48. D. Yamazaki, H. Hitomi, A. Nishiyama, Hypertension with diabetes mellitus complications. Hypertens. Res. 41(Mar 3), 147–156 (2018). https://doi.org/10.1038/s41440-017-0008-y . Epub 2018 Jan 22. PMID: 29353881 - PubMed
  49. I. Pearce, R. Simó, M. Lövestam-Adrian, D.T. Wong, M. Evans, Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review. Diabetes Obes. Metab. 21(Mar 3), 467–478 (2019). https://doi.org/10.1111/dom.13550 . Epub 2018 Oct 29. PMID: 30280465; PMCID: PMC6667892 - PubMed
  50. R. Klein, M.D. Knudtson, K.E. Lee, R. Gangnon, B.E. Klein, The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115(Nov 11), 1859–1868 (2008). https://doi.org/10.1016/j.ophtha.2008.08.023 . PMID: 19068374; PMCID: PMC2761813 - PubMed
  51. R. Klein, B.E. Klein, S.E. Moss, K.J. Cruickshanks, The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105(10), 1801–1815 (1998). https://doi.org/10.1016/S0161-6420(98)91020-X . PMID: 9787347 - PubMed
  52. R. Klein, B. Zinman, R. Gardiner, S. Suissa, S.M. Donnelly, A.R. Sinaiko, M.S. Kramer, P. Goodyer, S.E. Moss, T. Strand, M. Mauer, Renin-Angiotensin System Study. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes 54(Feb 2), 527–533 (2005). https://doi.org/10.2337/diabetes.54.2.527 . PMID: 15677511 - PubMed
  53. B. Matejko, J. Skupien, S. Mrozińska, M. Grzanka, K. Cyganek, B. Kiec-Wilk, M.T. Malecki, T. Klupa, Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy. Endocrine 48(Feb 1), 164–169 (2015). https://doi.org/10.1007/s12020-014-0274-2 . Epub 2014 May 6. PMID: 24798448 - PubMed
  54. M. Henricsson, L. Nyström, G. Blohmé, J. Ostman, C. Kullberg, M. Svensson, A. Schölin, H.J. Arnqvist, E. Björk, J. Bolinder, J.W. Eriksson, G. Sundkvist, The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 26(Feb 2), 349–354 (2003). https://doi.org/10.2337/diacare.26.2.349 . PMID: 12547861 - PubMed

Publication Types